Exact Mass: 576.255
Exact Mass Matches: 576.255
Found 145 metabolites which its exact mass value is equals to given mass value 576.255
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Bafetinib
Bafetinib is a tyrosine kinase inhibitor used to treat chronic myelogenous leukemia (CML), a cancer characterized by increased and unregulated growth of white blood cells in the bone marrow and the accumulation of these cells in the blood. Bafetinib is able to bind ABL with greater affinity than Imatinib (25-55 times more potent). It is therefore administered to patients with Imatinib resistance. Notably, Bafetinib is ineffective against the T315I mutation in BCR-ABL, and further research is necessary. C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
10-carboxy-5beta,14beta-dihydroxy-bufa-3,20,22-trienolid-5-O-beta-D-glucosid
16alpha-[(6-O-sulfo-beta-D-glucopyranosyl)oxy]pregn-5-ene-3beta,20-diol
(1S,4S,5S,6R,7R,8R,9R,10S)-1,6,8,15-tetra-acetoxy-9-benzoyloxy-4-hydroxy-dihydro-beta-agarofuran
5-hydroxyarenobufagin-3-O-4?,6?-dideoxy-alpha-L-allohexopyranose|kalantuboside B
10-methoxy-N(1)-methylburnamine-17-O-veratrate|10-methoxy-N1-methylburnamine-17-O-veratrate
17-methoxy-18-(3,4,5-trimethoxy-benzoyloxy)-yohimb-19-ene-16-carboxylic acid methyl ester|Deserpidein|Deserpideine|Deserpideine-B,HCl
C30H40O11_Methyl 5,6-diacetoxy-10-hydroxy-2,4b,7,7,10a,12a-hexamethyl-12-methylene-1,4,8-trioxohexadecahydro-2H-naphtho[1,2-h]isochromene-2-carboxylate
methyl 5,6-diacetyloxy-10-hydroxy-2,4b,7,7,10a,12a-hexamethyl-12-methylidene-1,4,8-trioxo-4a,5,6,6a,9,10,10b,11-octahydronaphtho[1,2-h]isochromene-2-carboxylate
methyl 5,6-diacetyloxy-10-hydroxy-2,4b,7,7,10a,12a-hexamethyl-12-methylidene-1,4,8-trioxo-4a,5,6,6a,9,10,10b,11-octahydronaphtho[1,2-h]isochromene-2-carboxylate_major
Asp Glu Lys Trp
Asp Glu Trp Lys
Asp Lys Glu Trp
Asp Lys Trp Glu
Asp Trp Glu Lys
Asp Trp Lys Glu
Glu Asp Lys Trp
Glu Asp Trp Lys
Glu Lys Asp Trp
Glu Lys Trp Asp
Glu Trp Asp Lys
Glu Trp Lys Asp
Phe Phe Thr Tyr
Phe Phe Tyr Thr
Phe His His His
Phe Thr Phe Tyr
Phe Thr Tyr Phe
Phe Tyr Phe Thr
Phe Tyr Thr Phe
His Phe His His
His His Phe His
His His His Phe
Lys Asp Glu Trp
Lys Asp Trp Glu
Lys Glu Asp Trp
Lys Glu Trp Asp
Lys Trp Asp Glu
Lys Trp Glu Asp
Thr Phe Phe Tyr
Thr Phe Tyr Phe
Thr Tyr Phe Phe
Trp Asp Glu Lys
Trp Asp Lys Glu
Trp Glu Asp Lys
Trp Glu Lys Asp
Trp Lys Asp Glu
Trp Lys Glu Asp
Tyr Phe Phe Thr
Tyr Phe Thr Phe
Tyr Thr Phe Phe
Bafetinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
[(2R,3R,4S,5R,6R)-2-[[(3S,4R,5R,8S,9S,10S,13R,14S,17R)-17-ethenyl-3-hydroxy-10-(hydroxymethyl)-13-methyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-4-yl]oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl] hydrogen sulfate
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]cyclopropanecarboxamide
(5S,6R,9R)-5-methoxy-14-[(4-methoxyphenyl)sulfonylamino]-3,6,9-trimethyl-2-oxo-N-propan-2-yl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide
(2S,3R,4S,5R,6R)-3,5-dihydroxy-6-[[(3R,5R,8R,9S,10S,13S,14S,17S)-17-[(1S)-1-hydroxyethyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-sulfooxyoxane-2-carboxylic acid
ethyl (3s)-3-(acetyloxy)-3-[(1r,2r,5r,6r,7r,8s,10s,11s,14s)-11-(furan-3-yl)-8-hydroxy-5-(2-hydroxypropan-2-yl)-2,6,10-trimethyl-3,13-dioxo-12,15-dioxatetracyclo[8.5.0.0¹,¹⁴.0²,⁷]pentadecan-6-yl]propanoate
(8s,21s)-16,27-dimethoxy-7,22-dimethyl-14,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.2¹⁰,¹³.1⁴,³⁰.1¹⁵,¹⁹.0³,⁸.0²⁵,³³.0²⁸,³²]heptatriaconta-1(30),2,4(34),10,12,15(35),16,18,25,27,32,36-dodecaene
(8s)-16,27-dimethoxy-7,22-dimethyl-29,31-dioxa-7,22-diazaoctacyclo[19.9.3.1⁴,³⁰.1¹⁰,¹⁴.1¹⁵,¹⁹.0³,⁸.0²⁵,³³.0²⁸,³²]hexatriaconta-1(30),2,4(34),10,12,14(36),15(35),16,18,25,27,32-dodecaen-13-ol
(3e,5s)-3-[(2e,4e,6e)-1-hydroxy-7-[(1s,6s)-6-[(1e,3e,5e)-7-hydroxy-7-[(3e,5s)-5-(hydroxymethyl)-1-methyl-2,4-dioxopyrrolidin-3-ylidene]hepta-1,3,5-trien-1-yl]cyclohex-2-en-1-yl]hepta-2,4,6-trien-1-ylidene]-5-(hydroxymethyl)-1-methylpyrrolidine-2,4-dione
12-hydroxy-16-methyl-15-(6-oxopyran-3-yl)-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-oxapentacyclo[9.7.0.0²,⁸.0⁵,⁷.0¹²,¹⁶]octadecane-2-carbaldehyde
15-Oxokaura-16-ene-2,3,6,7,11-pentaol pentaacetate
{"Ingredient_id": "HBIN001717","Ingredient_name": "15-Oxokaura-16-ene-2,3,6,7,11-pentaol pentaacetate","Alias": "NA","Ingredient_formula": "C30H40O11","Ingredient_Smile": "CC(=O)OC1CC2CC3(C1C4(CC(C(C(C4C(C3OC(=O)C)OC(=O)C)(C)C)OC(=O)C)OC(=O)C)C)C(=O)C2=C","Ingredient_weight": "576.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "458","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101421772","DrugBank_id": "NA"}